CU20070232A7 - USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS - Google Patents
USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERSInfo
- Publication number
- CU20070232A7 CU20070232A7 CU20070232A CU20070232A CU20070232A7 CU 20070232 A7 CU20070232 A7 CU 20070232A7 CU 20070232 A CU20070232 A CU 20070232A CU 20070232 A CU20070232 A CU 20070232A CU 20070232 A7 CU20070232 A7 CU 20070232A7
- Authority
- CU
- Cuba
- Prior art keywords
- bipolar disorders
- agomelatine
- treatment
- obtaining
- medicines
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title abstract 4
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002629 agomelatine Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a la utilización de la agomelatina o N-[2-(7-metoxi-1-naftil)acetamida sola o en asociación para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares, principalmente de los trastornos bipolares de los tipos I y II, y más particularmente de los trastornos bipolares de tipo I.The present invention relates to the use of agomelatine or N- [2- (7-methoxy-1-naphthyl) acetamide alone or in association for obtaining medicaments for the treatment of bipolar disorders, mainly bipolar disorders of types I and II, and more particularly of type I bipolar disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070232A CU20070232A7 (en) | 2007-10-15 | 2007-10-15 | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070232A CU20070232A7 (en) | 2007-10-15 | 2007-10-15 | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20070232A7 true CU20070232A7 (en) | 2010-01-22 |
Family
ID=44280840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20070232A CU20070232A7 (en) | 2007-10-15 | 2007-10-15 | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20070232A7 (en) |
-
2007
- 2007-10-15 CU CU20070232A patent/CU20070232A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200700084A (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF THE GENERALIZED ANXIETY DISORDER | |
| EA200601449A1 (en) | APPLICATION OF AGOMELATIN TO OBTAIN MEDICINAL AGENTS INTENDED FOR THE TREATMENT OF SLEEP DISORDERS IN A PATIENT WITH DEPRESSION | |
| CR9426A (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS | |
| AR063896A1 (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF SMITH MAGENIS SYNDROME | |
| AR080150A1 (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF THE OBSESSIVE COMPULSIVE DISORDER (TOC) | |
| CL2012002285A1 (en) | Crystalline form of 4 - {(1s, 2s) -2 - [((r) -4-cyclobutyl-2-methylpiperazin-1-yl) carbonyl] cyclopropyl] benzamide; Pharmaceutical composition, and its use to treat schizophrenia, narcolepsy, excessive daytime sleepiness, obesity, cognitive disorder associated with schizonphrenia. | |
| CU20070232A7 (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS | |
| PA8800301A1 (en) | CRYSTAL CHEMOTHERAPEUTIC PRODUCTS | |
| AR063895A1 (en) | USE OF AGOMELATINE FOR THE OBTAINING OF DRUGS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUCOMALACY | |
| CU20070070A7 (en) | PHARMACEUTICAL COMPOSITION OF AGOMELATIN | |
| UA88322C2 (en) | Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder | |
| EA200601450A1 (en) | NEW COMBINATION OF AGOMELATIN AND THE TIMOR-REGULATING REMEDY AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS |